Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...
Critical analyses of AI usually adopt a stance of defensive humanism. Instead, Nan Da interrogates its mode of reasoning. How ...
Q3 2025 Earnings Call November 7, 2025 10:00 AM ESTCompany ParticipantsPearce Hammond - Vice President of Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback